Literature DB >> 23162078

Unifying the genomics-based classes of cancer fusion gene partners: large cancer fusion genes are evolutionarily conserved.

Libia M Pava1, Daniel T Morton, Ren Chen, George Blanck.   

Abstract

BACKGROUND: Genes that fuse to cause cancer have been studied to determine molecular bases for proliferation, to develop diagnostic tools, and as targets for drugs. To facilitate identification of additional, cancer fusion genes, following observation of a chromosomal translocation, we have characterized the genomic features of the fusion gene partners. Previous work indicated that cancer fusion gene partners, are either large or evolutionarily conserved in comparison to the neighboring genes in the region of a chromosomal translocation. These results raised the question of whether large cancer fusion gene partners were also evolutionarily conserved. METHODS AND
RESULTS: We developed two methods for quantifying evolutionary conservation values, allowing the conclusion that both large and small cancer fusion gene partners are more evolutionarily conserved than their neighbors. Additionally, we determined that cancer fusion gene partners have more 3' untranslated region secondary structures than do their neighbors.
CONCLUSION: Coupled with previous algorithms, with or without transcriptome approaches, we expect these results to assist in the rapid and efficient use of chromosomal translocations to identify cancer fusion genes. The above parameters for any gene of interest can be accessed at www.cancerfusiongenes.com.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23162078

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   4.069


  2 in total

1.  De novo, systemic, deleterious amino acid substitutions are common in large cytoskeleton-related protein coding regions.

Authors:  Rebecca J Stoll; Grace R Thompson; Mohammad D Samy; George Blanck
Journal:  Biomed Rep       Date:  2016-12-08

2.  Flat cells come full sphere: Are mutant cytoskeletal-related proteins oncoprotein-monsters or useful immunogens?

Authors:  Michele L Parry; George Blanck
Journal:  Hum Vaccin Immunother       Date:  2015-07-30       Impact factor: 3.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.